Spots Global Cancer Trial Database for Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer
Official Title: Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer : Faisability and Toxicity Study
Study ID: NCT04680715
Conditions
Interventions
Study Description
Brief Summary: Phase II study; open recruitment, multicentrique. The aim of this clinical research is to evaluate faisability and toxicity of the per-operative radiotherapy using PAPILLON + TM device for localized breast cancers patients over 65 years.
Detailed Description:
Keywords
Eligibility
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Pôle Santé République, Clermont-Ferrand, , France
Centre Antoine Lacassagne, Nice, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
